3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
2
Triple Negative Breast Neoplasms
1
Pancreatic Neoplasms
1
Nasopharyngeal Carcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
pembrolizumab
33
Cisplatin
23
Carboplatin
15
Cetuximab
14
Magnetic Resonance Spectroscopy
13
Specimen Handling
10
Radiotherapy, Intensity-Modulated
10
Paclitaxel
9
Platinum
8
Nivolumab
8
1,2-diaminocyclohexaneplatinum II citrate
8
Docetaxel
7
atezolizumab
5
Taxes
5
Radiotherapy
5
Biopsy
5
Radiation
4
Immunoglobulin G
4
Fluorouracil
4
Disulfides
4
Bevacizumab
4
(225)Ac-DOTA-c(RGDyK)
4
dostarlimab
3
cemiplimab
3
Fulvestrant
3
dehydroftorafur
2
budigalimab
2
amivantamab
2
abemaciclib
2
Tiragolumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
camrelizumab
×
30 days
×
Clear all
No trials found.